Quick Answer
Vitamin D Bone Strength Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: The first group includes supplements supported by a robust theoretical foundation and extensive empirical evidence confirming their efficacy and safety.
Key Takeaways
- 01The first group includes supplements supported by a robust theoretical foundation and extensive empirical evidence confirming their efficacy and safety. [Soltani Mohammad (2026)]
- 02The second group comprises supplements with a plausible scientific rationale but inconsistent evidence regarding their effectiveness, necessitating further research. [Soltani Mohammad (2026)]
- 03Its anti‐inflammatory properties and role in reducing fracture risk, muscle weakness, and tendinopathy are well‐documented [,]. [Soltani Mohammad (2026)]
- 041 2 3 1 4 5 6 7 8 9 10 11 Dietary supplements, defined as nutrients or compounds ingested to enhance health or performance beyond habitual diets [], are widely used by athletes and the general population [,]. [Soltani Mohammad (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin D Bone Strength Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- The first group includes supplements supported by a robust theoretical foundation and extensive empirical evidence confirming their efficacy and safety. [Soltani Mohammad (2026); evidence level 1]
- The second group comprises supplements with a plausible scientific rationale but inconsistent evidence regarding their effectiveness, necessitating further research. [Soltani Mohammad (2026); evidence level 1]
- Its anti‐inflammatory properties and role in reducing fracture risk, muscle weakness, and tendinopathy are well‐documented [,]. [Soltani Mohammad (2026); evidence level 1]
- 1 2 3 1 4 5 6 7 8 9 10 11 Dietary supplements, defined as nutrients or compounds ingested to enhance health or performance beyond habitual diets [], are widely used by athletes and the general population [,]. [Soltani Mohammad (2026); evidence level 1]
- Specifically, 48.0% (12/25) of participants in the alfacalcidol group and 12.0% (3/25) in the control group achieved improvement in muscle mass or function, yielding an absolute difference of 36.0% (95% CI 12.6% – 59.4%; P = 0.005), with a relative risk (RR) of 1.69 (95% CI 1.13–2.53). [Wang L (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources